In the last trading session, 2.32 million shares of the Aptose Biosciences Inc (NASDAQ:APTO) were traded, and its beta was 0.91. Most recently the company’s share price was $0.24, and it changed around -$0.01 or -3.87% from the last close, which brings the market valuation of the company to $14.34M. APTO currently trades at a discount to its 52-week high of $2.68, offering almost -1016.67% off that amount. The share price’s 52-week low was $0.13, which indicates that the current value has risen by an impressive 45.83% since then. We note from Aptose Biosciences Inc’s average daily trading volume that its 10-day average is 37.4 million shares, with the 3-month average coming to 6.36 million.
Aptose Biosciences Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended APTO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Instantly APTO has showed a red trend with a performance of -3.87% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3895 on recent trading dayincreased the stock’s daily price by 38.38%. The company’s shares are currently down -90.51% year-to-date, but still up 41.60% over the last five days. On the other hand, Aptose Biosciences Inc (NASDAQ:APTO) is 35.39% up in the 30-day period. We can see from the shorts that 0.19 million shares have been sold at a short interest cover period of 0.15 day(s).
Aptose Biosciences Inc (APTO) estimates and forecasts
Aptose Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -68.25 percent over the past six months and at a 76.39% annual growth rate that is well above the industry average of 16.70%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 10.18%.
APTO Dividends
Aptose Biosciences Inc’s next quarterly earnings report is expected to be released in January.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 16.39% of Aptose Biosciences Inc shares, and 16.68% of them are in the hands of institutional investors. The stock currently has a share float of 19.96%. Aptose Biosciences Inc stock is held by 31.0 institutions, with DOHENY ASSET MANAGEMENT /CA being the largest institutional investor. By 2024-06-30, it held 0.3849% of the shares, which is about 50550.0 shares worth $0.32 million.
CALDWELL SUTTER CAPITAL, INC., with 0.0007% or 92.0 shares worth $70.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
